NCT05795959Completed
Ensuring Precision-Medicine Delivery for Veterans With Lung Cancer
Source: ClinicalTrials.gov · Last updated 12 Feb 2025
Brief summary (registry, in English)
The goal of this study is to learn if using a lay VA volunteer, who will assist patients with education regarding precision medicine, can improve care quality and outcomes for Veteran patients with lung cancer.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 46 (actual)
- First submitted
- 9 Mar 2023
- Start date
- 20 Apr 2023
- Primary completion date
- 20 May 2024
- Lead sponsor
- Stanford University
- Diseases
- Lung cancer
- NCT number
- NCT05795959
What you commit to
- Study type: Interventional
- Participants enrolled: 46
- From 20 Apr 2023 to the primary completion date, 20 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Inability to consent to the study, severe mental illness (e.g. schizophrenia) or institutionalization.
Other
- Patients who anticipate moving care outside the Veterans Affairs Palo Alto Health Care System within 6 months.
Who the study is looking for
- All patients 18 years old that have been newly diagnosed with any stage of lung cancer.
- Patients must have the ability to understand and willingness to provide verbal consent.
- Participants must speak English.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| VA Palo Alto Coordinator of this site? Confirm its status | Palo Alto | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.